LCG
TECH icon

Lisanti Capital Growth’s Bio-Techne TECH Stock Holding History

Lisanti Capital Growth’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-30,140
Closed -$3.26M – 139
2022
Q1 		$3.26M Sell
30,140
-2,640
-8% -$272K 0.37% 96
2021
Q4 		$4.24M Sell
32,780
-1,140
-3% -$140K 0.61% 69
2021
Q3 		$4.11M Hold
33,920
– – 0.61% 69
2021
Q2 		$3.82M Hold
33,920
– – 0.47% 86
2021
Q1 		$3.24M Buy
33,920
+4,480
+15% +$409K 0.42% 93
2020
Q4 		$2.34M Buy
29,440
+7,860
+36% +$569K 0.32% 94
2020
Q3 		$1.34M Sell
21,580
-1,680
-7% -$109K 0.25% 94
2020
Q2 		$1.54M Buy
+23,260
New +$1.39M 0.31% 99

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Lisanti Capital Growth's TECH Position: Q2 2022 in Review

Lisanti Capital Growth sold out of Bio-Techne (TECH) in Q2 2022, closing a stake of 30,140 shares — an estimated $3.26M sold.

Lisanti Capital Growth first reported a position in TECH in Q2 2020 and held it in 8 quarters. The position peaked at $4.24M in Q4 2021. 550 funds tracked by Wall St. Rank hold TECH as of Q2 2022.

  • Lisanti Capital Growth reported no remaining Bio-Techne position as of Q2 2022 after selling out during the quarter.
  • Lisanti Capital Growth sold 30,140 Bio-Techne shares in Q2 2022, an estimated $3.26M.
  • Lisanti Capital Growth first reported a position in Bio-Techne in Q2 2020 and held it in 8 quarters.
  • Lisanti Capital Growth's Bio-Techne position peaked at $4.24M in Q4 2021.
  • 550 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2022.

Based on Lisanti Capital Growth's 13F filing for Q2 2022, filed 3 Aug 2022.